Description: GeneThera, Inc., a biotechnology company, focuses on developing molecular diagnostic tests, therapeutics, and vaccines to control emerging diseases in animals and humans. The company develops specific assays for chronic wasting disease in elk and deer, and mad cow disease in cattle; diagnostics for E.coli. diseases; and Johne's disease in dairy cattle. Its molecular diagnostic assays solutions use real time fluorogenic polymerase chain reaction technology to detect the presence of infectious disease from the blood of live animals. The company also develops therapeutic vaccines using RNA interference technology; and adenovirus and adeno associate virus -based recombinant DNA vaccines for zoonotic pathogens using viral DNA purification technology. In addition, it offers Herd Guard, a Johne's management solution; HerdCheck, a diagnostic product; HerdSafe, a purification and recombinant based DNA vaccine; and HerdSoft, a Web-based Johne's disease management solution. The company was founded in 1995 and is based in Denver, Colorado.
Home Page: www.genethera.net
3051 West 105th Avenue
Westminster,
CO
80035
United States
Phone:
720 587 5100
Officers
| Name | Title |
|---|---|
| Dr. Antonio Milici M.D., Ph.D. | Founder, Chairman, CEO, President & Chief Scientific Officer |
| Ms. Tannya L. Irizarry | Chief Administrative Officer, Interim CFO, Secretary & Compliance Officer |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 2 |